Impact of Payload Hydrophobicity on the Stability of Antibody-Drug Conjugates

被引:76
作者
Buecheler, Jakob W. [1 ,2 ]
Winzer, Matthias [2 ]
Tonillo, Jason [2 ]
Weber, Christian [2 ]
Gieseler, Henning [3 ]
机构
[1] Friedrich Alexander Univ Erlangen Nurnberg, Div Pharmaceut, D-91054 Erlangen, Germany
[2] Merck KGaA, Discovery & Dev Technol, D-64293 Darmstadt, Germany
[3] GILYOS GmbH, D-97076 Wurzburg, Germany
关键词
antibody-drug conjugates; protein aggregation; stability; conjugation; thermal analysis; physicochemical properties; MULTIDIMENSIONAL CHROMATOGRAPHY; STRUCTURAL-CHARACTERIZATION; PHYSICOCHEMICAL STABILITY; AGGREGATION; CANCER; PHARMACOKINETICS; CHEMISTRY; DESIGN; MODEL; SITE;
D O I
10.1021/acs.molpharmaceut.8b00177
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In silico screening of toxin payloads typically employed in ADCs revealed a wide range of hydrophobicities and sizes as measured by logP and topological polar surface area (tPSA) values. These descriptors were used to identify three nontoxic surrogate payloads that encompass the range of hydrophobicity defined by the ADC toxin training set. The uniform drug to antibody ratio (DAR) ADCs were prepared for each surrogate payload by conjugation to the interchain cysteine residues of a model IgG1 subtype mAb. Linkage of these surrogate payloads to a common mAb with a matched DAR value allowed for preliminary analytical interrogation of the influence of payload hydrophobicity on global structure, self-association, and aggregation properties. The results of differential scanning fluorimetry and dynamic light scattering experiments clearly revealed a direct correlation between the destabilization of the native mAb structure and the increasing payload hydrophobicity. Also, self-association/aggregation propensity examined by self-interaction biolayer interferometry or size exclusion HPLC was consistent with increased conversion of the monomeric mAb to higher order aggregated species, with the degree of conversion directly proportional to the payload hydrophobicity. In summary, these findings prove that the payload-dependent structure destabilization and enhanced propensity to self-associate/aggregate driven by the increasing payload hydrophobicity contribute to reduced ADC stability and more complex behavior when assessing exposure and safety/efficacy relationships.
引用
收藏
页码:2656 / 2664
页数:9
相关论文
共 39 条
[1]   Impact of linker and conjugation chemistry on antigen binding, Fc receptor binding and thermal stability of model antibody-drug conjugates [J].
Acchione, Mauro ;
Kwon, Hyewon ;
Jochheim, Claudia M. ;
Atkins, William M. .
MABS, 2012, 4 (03) :362-372
[2]   Auristatin Antibody Drug Conjugate Physical Instability and the Role of Drug Payload [J].
Adem, Yilma T. ;
Schwarz, Kelly A. ;
Duenas, Eileen ;
Patapoff, Thomas W. ;
Galush, William J. ;
Esue, Osigwe .
BIOCONJUGATE CHEMISTRY, 2014, 25 (04) :656-664
[3]   Investigation into Temperature-Induced Aggregation of an Antibody Drug Conjugate [J].
Beckley, Nia S. ;
Lazzareschi, Kathlyn P. ;
Chih, Hung-Wei ;
Sharma, Vikas K. ;
Flores, Heather L. .
BIOCONJUGATE CHEMISTRY, 2013, 24 (10) :1674-1683
[4]   A rapid on-line method for mass spectrometric confirmation of a cysteine-conjugated antibody-drug-conjugate structure using multidimensional chromatography [J].
Birdsall, Robert E. ;
Shion, Henry ;
Kotch, Frank W. ;
Xu, April ;
Porter, Thomas J. ;
Chen, Weibin .
MABS, 2015, 7 (06) :1036-1044
[5]   Current possibilities of liquid chromatography for the characterization of antibody-drug conjugates [J].
Bobaly, Balazs ;
Fleury-Souverain, Sandrine ;
Beck, Alain ;
Veuthey, Jean-Luc ;
Guillarme, Davy ;
Fekete, Szabolcs .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 147 :493-505
[6]   Effects of Charge on Antibody Tissue Distribution and Pharmacokinetics [J].
Boswell, C. Andrew ;
Tesar, Devin B. ;
Mukhyala, Kiran ;
Theil, Frank-Peter ;
Fielder, Paul J. ;
Khawli, Leslie A. .
BIOCONJUGATE CHEMISTRY, 2010, 21 (12) :2153-2163
[7]   Conjugation Site Heterogeneity Causes Variable Electrostatic Properties in Fc Conjugates [J].
Boylan, Nicholas J. ;
Zhou, Wen ;
Proos, Robert J. ;
Tolbert, Thomas J. ;
Wolfe, Janet L. ;
Laurence, Jennifer S. .
BIOCONJUGATE CHEMISTRY, 2013, 24 (06) :1008-1016
[8]   Development of a protein nanoparticle platform for targeting EGFR expressing cancer cells [J].
Buecheler, Jakob W. ;
Howard, Christopher B. ;
de Bakker, Christopher J. ;
Goodall, Stephen ;
Jones, Martina L. ;
Win, Thinzar ;
Peng, Tao ;
Tan, Cher Heng ;
Chopra, Akhil ;
Mahler, Stephen M. ;
Lim, Sierin .
JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY, 2015, 90 (07) :1230-1236
[9]   Expanding the Reach of Antibody-Drug Conjugates [J].
Chari, Ravi V. J. .
ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (11) :974-976
[10]   Photoinduced Aggregation of a Model Antibody-Drug Conjugate [J].
Cockrell, Gregory M. ;
Wolfe, Michael S. ;
Wolfe, Janet L. ;
Schoeneich, Christian .
MOLECULAR PHARMACEUTICS, 2015, 12 (06) :1784-1797